CEGEDIM to acquire Dendrite International
French database and software company CEGEDIM has signed a definitive merger agreement with US-based Dendrite International to create a major player in diversified sales, marketing, clinical and compliance solutions to the global life sciences and pharmaceutical industry.
French database and software company CEGEDIM has signed a definitive merger agreement with US-based Dendrite International to create a major player in diversified sales, marketing, clinical and compliance solutions to the global life sciences and pharmaceutical industry.
The combined company is expected to have estimated pro forma annual revenues of UA$1.1bn and will operate in more than 75 countries throughout Europe, the Americas and Asia Pacific.
The merger, which is contingent upon the approval of Dendrite shareholders, receipt of regulatory approvals and other customary closing conditions, is expected to close within the next few months.
'We are excited to join forces with Dendrite's team to create a truly global business with increased international reach, a broader scope of product offerings and the strength to invest in the development of innovative technologies,' said Jean-Claude Labrune, founder, chairman and ceo of CEGEDIM. 'As a combined organisation we will be better able to serve our clients in our competitive global marketplace.'